{
    "2018-12-17": [
        [
            {
                "time": "",
                "original_text": "同仁堂因过期蜂蜜股价下挫 43只基金持仓躺枪 重仓股票异动",
                "features": {
                    "keywords": [
                        "同仁堂",
                        "过期蜂蜜",
                        "股价下挫",
                        "基金持仓"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "深港通连续6个交易日净流入 资金偏爱个股变成这些股",
                "features": {
                    "keywords": [
                        "深港通",
                        "净流入",
                        "资金偏爱"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一致性评价成为继“4+7”后热门话题，药品申报热度不减",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "4+7",
                        "药品申报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“复星系”独角兽在港提交上市申请资料 估值达200亿元",
                "features": {
                    "keywords": [
                        "复星系",
                        "独角兽",
                        "上市申请",
                        "估值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国都香港：经济下行风险增大 港股或下探25000点",
                "features": {
                    "keywords": [
                        "国都香港",
                        "经济下行",
                        "港股",
                        "下探"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "港股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星系重启买买买 旗下公司上市加速",
                "features": {
                    "keywords": [
                        "复星系",
                        "买买买",
                        "上市加速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中金：近期外资动向及成因分析",
                "features": {
                    "keywords": [
                        "中金",
                        "外资动向",
                        "成因分析"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "老沙:环球股市都进入了“垃圾时间”",
                "features": {
                    "keywords": [
                        "老沙",
                        "环球股市",
                        "垃圾时间"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全球市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:政策多发扰动期,建议关注品牌中药的配置价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策多发",
                        "品牌中药",
                        "配置价值"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业2019年年度投资策略报告:继续看好创新药企及细分领域龙头企业的發展",
                "features": {
                    "keywords": [
                        "医药行业",
                        "创新药企",
                        "细分领域龙头企业",
                        "年度策略"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}